PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 4083978

  • 1. [Treatment of virilizing adrenal hyperplasia in adolescents. Use and side-effects of dexamethasone].
    Job JC, Munck A, Chaussain JL, Canlorbe P.
    Arch Fr Pediatr; 1985 Nov; 42(9):765-9. PubMed ID: 4083978
    [Abstract] [Full Text] [Related]

  • 2. [A clinical study of congenital adrenal hyperplasia].
    Nanbu A, Kumamoto Y, Tachiki H, Itoh N, Mikuma N, Tsunekawa T, Takagi Y, Maruta H.
    Hinyokika Kiyo; 1989 Nov; 35(11):1831-7. PubMed ID: 2559616
    [Abstract] [Full Text] [Related]

  • 3. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM, Simm D, Beier C, Dörr HG.
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [Abstract] [Full Text] [Related]

  • 4. [Occurrence of severe striae in adolescents with congenital adrenal hyperplasia and 21-hydroxylation deficiency treated with dexamethasone].
    Guest G, Rappaport R, Philippe F, Thibaud E.
    Arch Fr Pediatr; 1983 Jan; 40(6):453-6. PubMed ID: 6605132
    [Abstract] [Full Text] [Related]

  • 5. [Congenital virilizing adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Study of eleven cases (author's transl)].
    Dunand A, Roger M, Chaussain JL, Nocton F, Job JC.
    Sem Hop; 1983 Jan; 57(33-36):1392-7. PubMed ID: 6270798
    [Abstract] [Full Text] [Related]

  • 6. Amenorrhea related to progestin excess in congenital adrenal hyperplasia.
    Rosenfield RL, Bickel S, Razdan AK.
    Obstet Gynecol; 1980 Aug; 56(2):208-15. PubMed ID: 7393510
    [Abstract] [Full Text] [Related]

  • 7. [Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia].
    Sulcová J, Lisá L, Dvorák P, Hampl R, Stárka L.
    Cesk Pediatr; 1990 Jun; 45(6):353-6. PubMed ID: 2289256
    [Abstract] [Full Text] [Related]

  • 8. Repeated successful induction of fertility after replacing hydrocortisone with dexamethasone in a patient with congenital adrenal hyperplasia and testicular adrenal rest tumors.
    Claahsen-van der Grinten HL, Otten BJ, Sweep FC, Hermus AR.
    Fertil Steril; 2007 Sep; 88(3):705.e5-8. PubMed ID: 17517401
    [Abstract] [Full Text] [Related]

  • 9. [Virilizing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: early diagnosis and response to 2 treatment schedules].
    Cattani A, Mahaha D, Michaud P, Rodríguez JA, López JM, García H, Foradori A, Velásquez CG.
    Rev Chil Pediatr; 1984 Sep; 55(6):374-9. PubMed ID: 6536989
    [No Abstract] [Full Text] [Related]

  • 10. Prenatal Treatment with Dexamethasone in Suspected Congenital Adrenal Hyperplasia and Orofacial Cleft: a Case Report and Review of the Literature.
    Rijk Y, van Alfen-van der Velden J, Claahsen-van der Grinten HL.
    Pediatr Endocrinol Rev; 2017 Sep; 15(1):21-25. PubMed ID: 28845624
    [Abstract] [Full Text] [Related]

  • 11. Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Pang SY, Pollack MS, Marshall RN, Immken L.
    N Engl J Med; 1990 Jan 11; 322(2):111-5. PubMed ID: 2403652
    [No Abstract] [Full Text] [Related]

  • 12. Effects of long term dexamethasone treatment in adult patients with congenital adrenal hyperplasia.
    Horrocks PM, London DR.
    Clin Endocrinol (Oxf); 1987 Dec 11; 27(6):635-42. PubMed ID: 2843311
    [Abstract] [Full Text] [Related]

  • 13. Prenatal dexamethasone treatment of fetuses at risk for congenital adrenal hyperplasia: benefits and concerns.
    Ritzén EM.
    Semin Neonatol; 2001 Aug 11; 6(4):357-62. PubMed ID: 11972437
    [Abstract] [Full Text] [Related]

  • 14. Gender related differences in glucocorticoid therapy and growth outcomes among pubertal children with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH).
    Deslauriers JR, Lenz AM, Root AW, Diamond FB, Bercu BB.
    J Pediatr Endocrinol Metab; 2012 Aug 11; 25(9-10):977-81. PubMed ID: 23426829
    [Abstract] [Full Text] [Related]

  • 15. Androgen-secreting adrenal tumors.
    Sciarra F, Tosti-Croce C, Toscano V.
    Minerva Endocrinol; 1995 Mar 11; 20(1):63-8. PubMed ID: 7651284
    [Abstract] [Full Text] [Related]

  • 16. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z, Rostami-Hodjegan A, Memmott A, Doane A, Ibbotson V, Newell-Price J, Tucker GT, Ross RJ.
    Clin Endocrinol (Oxf); 2006 Jul 11; 65(1):45-50. PubMed ID: 16817818
    [Abstract] [Full Text] [Related]

  • 17. Variable efficacy of glucocorticoids in congenital adrenal hyperplasia.
    Hansen JW, Loriaux DL.
    Pediatrics; 1976 Jun 11; 57(6):942-7. PubMed ID: 934750
    [Abstract] [Full Text] [Related]

  • 18. [Adrenal hyperplasia of late onset: optimization of therapy by measuring the circadian variation of serum 17-OH-progesterone].
    Contreras P, Rojas A, Vega I.
    Rev Med Chil; 1989 Jun 11; 116(6):552-7. PubMed ID: 2749040
    [Abstract] [Full Text] [Related]

  • 19. Adrenal virilism due to 21-hydroxylase deficiency in the postmenarchial female.
    Riddick DH, Hammond CB.
    Obstet Gynecol; 1975 Jan 11; 45(1):21-4. PubMed ID: 163016
    [Abstract] [Full Text] [Related]

  • 20. Fertility among women with classical congenital adrenal hyperplasia: report of seven cases where treatment was started after 9 years of age.
    Kulshreshtha B, Marumudi E, Khurana ML, Kriplani A, Kinra G, Gupta DK, Kucheria K, Khadgawat R, Gupta N, Seith A, Ammini AC.
    Gynecol Endocrinol; 2008 May 11; 24(5):267-72. PubMed ID: 18569031
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.